Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

28.75USD
3:20pm EDT
Price Change (% chg)

$-0.51 (-1.74%)
Prev Close
$29.26
Open
$29.19
Day's High
$29.32
Day's Low
$28.74
Volume
4,637,485
Avg. Vol
6,090,197
52-wk High
$32.96
52-wk Low
$27.76

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.68
Market Cap (Mil.): $186,451.50
Shares Outstanding (Mil.): 6,372.23
Dividend: 0.26
Yield (%): 3.55

Financials

  PFE.N Industry Sector
P/E (TTM): 18.34 35.82 36.29
EPS (TTM): 1.60 -- --
ROI: -- 18.85 18.13
ROE: -- 19.57 18.95
Search Stocks

AstraZeneca raises forecasts after seeing off Pfizer

LONDON - AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago.

6:51am EDT

UPDATE 3-AstraZeneca raises forecasts after seeing off Pfizer

* Now assuming generic Nexium in U.S. from Oct. 1 (Adds CEO comments from conference call, further analyst comment)

6:45am EDT

BRIEF-Astra CEO says Nov. 18 investor day to focus on progress, no comment on Pfizer

July 31 - AstraZeneca PLC CEO Pascal Soriot told reporters: * CEO says can't comment on Pfizer, says November 18 investor day will focus on

5:31am EDT

BG, Shell boost Britain's FTSE after profits rise

EDINBURGH, July 31 - British blue chip shares rose on Thursday, boosted by better than expected earnings reports, with the oil and gas sector lifted by rising profits.

3:27am EDT

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

LONDON, July 31 - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.

2:18am EDT

Pfizer to buy Baxter's vaccines unit for $635 million

- Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million.

30 Jul 2014

UPDATE 1-Pfizer to buy Baxter's vaccines unit for $635 mln

July 30 - Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million.

30 Jul 2014

CORRECTED-Pfizer to buy two Baxter vaccines for $635 mln

(Corrects third paragraph to " ... outside the United States" from " ... in the United States")

30 Jul 2014

Pfizer leaves investors guessing on intentions for Astra

- Pfizer Inc , which in May abandoned its $118 billion bid for AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. | Video

29 Jul 2014

US STOCKS-Wall Street ends down; Twitter rallies after-hours

* Merck up as results beat expectations, but Pfizer slips

29 Jul 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $100.51 -1.79
Novartis AG (NOVN.VX) CHF79.55 -0.80
Merck & Co., Inc. (MRK.N) $57.03 -1.05
Roche Holding Ltd. (ROG.VX) CHF264.70 -2.00
Abbott Laboratories (ABT.N) $42.11 -0.75
Bayer AG (BAYGn.DE) €98.92 -2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €78.62 +1.73
AstraZeneca plc (AZN.L) 4,344.50p -13.00
GlaxoSmithKline plc (GSK.L) 1,436.50p +11.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks